Explore 3 Stock Ideas & Industry Insights Download Free Report

News

PTL Limited Changes Nasdaq Ticker From PTLE to ZYN

PTL Limited filed a Form 6-K on November 12, 2026, disclosing that its board of directors approved a change in the trading symbol of its Class A ordinary shares on the Nasdaq Capital Market from "PTLE" to "ZYN," effective at the open of trading …

Aakashdeep | 12 November 2026

Chicago Atlantic BDC Reports Q3 2026 Results, Merger Pending

Chicago Atlantic BDC, Inc. filed a Current Report on Form 8-K on November 12, 2026, announcing its financial results for the third quarter ended September 30, 2026, and disclosing details of a pending merger with Chicago Atlantic Real Estate Finance, Inc.

Nitish Kishor | 12 November 2026

Inflection Point VII Files BCA Amendment No. 2 for Elroy Air Merger

Inflection Point Acquisition Corp. VII filed a Form 8-K on November 12, 2026, reporting that on November 11, 2026, it entered into the Second Amendment to the Business Combination Agreement with Merger Sub and Elroy Air, Inc., modifying stock exchange procedures and lock-up agreement …

Aditi Sarkar | 12 November 2026

Axalta-AkzoNobel Merger Faces UK CMA Phase 1 Review

Axalta Coating Systems Ltd. filed a Form 425 on November 11, 2026, disclosing that the UK Competition and Markets Authority has completed a Phase 1 review of the proposed merger with Akzo Nobel N.V. and identified competition concerns in the supply of vehicle refinish …

Manish Choudhary | 12 November 2026

This NASDAQ Healthcare Penny Stock Surges 65% Pre-Market After a $105 Million Spin-Out Financing

Addex is a Geneva-based, clinical-stage biopharmaceutical company developing small molecule allosteric modulators for neurological disorders. Its lead candidate, dipraglurant, is being evaluated for future development in brain injury recovery, and it has GABAB programs aimed at substance use disorders and chronic cough.

Nitish Kishor | 12 November 2026

Lower-End Guidance and a Sharp Cash Drop Send Alvotech (NASDAQ:ALVO) Penny Stock Down 8% Pre-Market

Alvotech is a biotechnology company that develops and manufactures biosimilar medicines, with an integrated operation in Reykjavik, Iceland. It has five approvedBiosimilarsmarketed across multiple global markets, sold largely through commercial partners.

Nitish Kishor | 12 November 2026

Aveanna Healthcare (NASDAQ:AVAH) Slips Pre-Market Today Despite Profit Jump and Higher 2026 Guidance

Aveanna is an Atlanta-based home care provider operating in 39 states, serving medically complex, high-cost patients with services such as nursing, hospice, rehabilitation, school-based nursing and enteral nutrition delivery. Its largest segment, private duty services, generated $574.2 million of third quarter revenue.

Nitish Kishor | 12 November 2026

Beyond Air (NASDAQ:XAIR): What's Behind the Penny Stock's 24% Pre-Market Slide

Beyond Air is a Garden City, New York-based commercial-stage medical device and biopharmaceutical company developing nitric oxide therapies. Its only commercial product, LungFit PH, is a cylinder-free system approved by the FDA for term and near-term neonates with hypoxic respiratory failure.

Nitish Kishor | 12 November 2026

Fennec Pharmaceuticals (NASDAQ:FENC) Shares Rise 4% Pre-Market Today as Third Quarter Product Sales Jump 56%

Fennec is a specialty pharmaceutical company based in Research Triangle Park, North Carolina. The company describes PEDMARK as the first and only FDA-approved therapy to reduce the risk of cisplatin-related hearing loss in pediatric patients with localized, non-metastatic solid tumors. A European version is …

Nitish Kishor | 12 November 2026

Why Is PepGen (NASDAQ:PEPG) Stock Up 4% Pre-Market Today After a $125 Million Offering?

PepGen is a Boston-based, clinical-stage biotechnology company founded in 2018. Its Enhanced Delivery Oligonucleotide technology uses cell-penetrating peptides to improve the uptake of conjugated oligonucleotide therapies. Its lead candidate, PGN-EDODM1, is being studied in myotonic dystrophy type 1 in the Phase 2 FREEDOM2-DM1 trial.

Nitish Kishor | 12 November 2026
Support

Hi! How can we help you today?

Loading…